Filing Details
- Accession Number:
- 0001385508-22-000058
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-16 16:05:15
- Reporting Period:
- 2022-05-13
- Accepted Time:
- 2022-05-16 16:05:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1385508 | Opiant Pharmaceuticals Inc. | OPNT | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1363558 | A Craig Collard | C/O Opiant Pharmaceuticals, Inc. 233 Wilshire Blvd., Suite 400 Santa Monica CA 90401 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-05-13 | 3,689 | $10.49 | 20,972 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $10.47 to $10.50. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.